Davanço, M.G.; Meulman, J.; da Silva, T.M.; Costa, F.; Bellorio, K.B.; Mundim, I.M.; Sampaio, A.C.C.; Teixeira, L.d.S.; Vespasiano, C.F.P.
Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions. Pharmaceutics 2023, 15, 1737.
https://doi.org/10.3390/pharmaceutics15061737
AMA Style
Davanço MG, Meulman J, da Silva TM, Costa F, Bellorio KB, Mundim IM, Sampaio ACC, Teixeira LdS, Vespasiano CFP.
Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions. Pharmaceutics. 2023; 15(6):1737.
https://doi.org/10.3390/pharmaceutics15061737
Chicago/Turabian Style
Davanço, Marcelo Gomes, Jessica Meulman, Thalita Martins da Silva, Fernando Costa, Karini Bruno Bellorio, Iram Moreira Mundim, Ana Carolina Costa Sampaio, Leonardo de Souza Teixeira, and Celso Francisco Pimentel Vespasiano.
2023. "Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions" Pharmaceutics 15, no. 6: 1737.
https://doi.org/10.3390/pharmaceutics15061737
APA Style
Davanço, M. G., Meulman, J., da Silva, T. M., Costa, F., Bellorio, K. B., Mundim, I. M., Sampaio, A. C. C., Teixeira, L. d. S., & Vespasiano, C. F. P.
(2023). Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions. Pharmaceutics, 15(6), 1737.
https://doi.org/10.3390/pharmaceutics15061737
